130 related articles for article (PubMed ID: 29375570)
1. From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis.
Mardente S; Mari E; Massimi I; Tafani M; Guerriero R; Morsilli O; Pulcinelli FM; Bianchi ME; Zicari A
Front Immunol; 2017; 8():1946. PubMed ID: 29375570
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
Figueiredo C; Blaszczyk R
J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
[TBL] [Abstract][Full Text] [Related]
3. Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions.
Börger AK; Eicke D; Wolf C; Gras C; Aufderbeck S; Schulze K; Engels L; Eiz-Vesper B; Schambach A; Guzman CA; Lachmann N; Moritz T; Martin U; Blasczyk R; Figueiredo C
Mol Med; 2016 Sep; 22():274-285. PubMed ID: 27262025
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.
Li J; Luo J; Luo YQ; Zhou M; Zhao L; Yao LJ; Dong H; Yang RN
Transfusion; 2014 Aug; 54(8):2106-17. PubMed ID: 24655355
[TBL] [Abstract][Full Text] [Related]
5. Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration.
Schlinker AC; Radwanski K; Wegener C; Min K; Miller WM
Biotechnol Bioeng; 2015 Apr; 112(4):788-800. PubMed ID: 25312394
[TBL] [Abstract][Full Text] [Related]
6. HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.
Gras C; Schulze K; Goudeva L; Guzman CA; Blasczyk R; Figueiredo C
Hum Gene Ther; 2013 Dec; 24(12):1018-28. PubMed ID: 24090417
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
[TBL] [Abstract][Full Text] [Related]
9. Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.
Massimi I; Guerriero R; Lotti LV; Lulli V; Borgognone A; Romani F; Barillà F; Gaudio C; Gabbianelli M; Frati L; Pulcinelli FM
Br J Clin Pharmacol; 2014 Dec; 78(6):1343-53. PubMed ID: 24902864
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.
Vogel S; Rath D; Borst O; Mack A; Loughran P; Lotze MT; Neal MD; Billiar TR; Gawaz M
Biochem Biophys Res Commun; 2016 Sep; 478(1):143-148. PubMed ID: 27449608
[TBL] [Abstract][Full Text] [Related]
11. Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.
Nguyen A; Bhavsar S; Riley E; Caponetti G; Agrawal D
Int Arch Otorhinolaryngol; 2016 Oct; 20(4):382-389. PubMed ID: 27746844
[No Abstract] [Full Text] [Related]
12. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.
Marsh AM; Nguyen AH; Parker TM; Agrawal DK
Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162
[TBL] [Abstract][Full Text] [Related]
15. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
17. Exosomal HMGB1 Promoted Cancer Malignancy.
Wang JD; Wang YY; Lin SY; Chang CY; Li JR; Huang SW; Chen WY; Liao SL; Chen CJ
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669632
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
19. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
20. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
